These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9407357)

  • 1. Current therapeutic trends in therapy for chronic viral hepatitis.
    Liaw YF
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S346-53. PubMed ID: 9407357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of chronic viral hepatitis.
    Main J
    J Hosp Infect; 1991 Jun; 18 Suppl A():335-40. PubMed ID: 1716277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic viral hepatitis.
    Marcellin P; Benhamou JP
    Baillieres Clin Gastroenterol; 1994 Jun; 8(2):233-53. PubMed ID: 7949457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic viral hepatitis.
    Dusheiko GM; Zuckerman AJ
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():107-20. PubMed ID: 8407692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A practical guide to the use of interferons in the management of hepatitis virus infections.
    Saracco G; Rizzetto M
    Drugs; 1997 Jan; 53(1):74-85. PubMed ID: 9010649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic viral hepatitis.
    Garcia G; Gentry KR
    Med Clin North Am; 1989 Jul; 73(4):971-83. PubMed ID: 2471027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B.
    Chien RN
    Hepatol Int; 2008 Sep; 2(3):296-303. PubMed ID: 19669257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of patients with dual hepatitis B virus and C virus infection to interferon therapy.
    Liaw YF; Chien RN; Lin SM; Yeh CT; Tsai SL; Sheen IS; Chu CM
    J Interferon Cytokine Res; 1997 Aug; 17(8):449-52. PubMed ID: 9282824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis].
    Karino Y
    Hokkaido Igaku Zasshi; 1993 May; 68(3):297-309. PubMed ID: 7686526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hepatitis C virus in dual and triple hepatitis virus infection.
    Liaw YF
    Hepatology; 1995 Oct; 22(4 Pt 1):1101-8. PubMed ID: 7557857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hepatitis D.
    Niro GA; Rosina F; Rizzetto M
    J Viral Hepat; 2005 Jan; 12(1):2-9. PubMed ID: 15655042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent hepatitis C virus and hepatitis delta virus superinfection in patients with chronic hepatitis B virus infection.
    Liaw YF; Chien RN; Chen TJ; Sheen IS; Chu CM
    J Med Virol; 1992 Aug; 37(4):294-7. PubMed ID: 1402827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The course of inactive hepatitis B in hepatitis-C-coinfected patients treated with interferon and ribavirin.
    Viganò M; Aghemo A; Iavarone M; Rumi MG; Agnelli F; Lampertico P; Donato MF; Colombo M
    Antivir Ther; 2009; 14(6):789-96. PubMed ID: 19812441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy in patients with chronic type B hepatitis].
    Chien RN; Liaw YF
    J Formos Med Assoc; 1995 Jun; 94 Suppl 1():S1-9. PubMed ID: 7549584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
    Marinos G; Naoumov NV; Williams R
    Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.